The bipartisan Main Street Pharmacy Access Act (H.R. 3164/S. 2426), which would allow Medicare to reimburse pharmacists for testing and treating certain respiratory illnesses in states that already authorize those services, cleared the House Committee on Ways and Means on May 21.

The Academy of Managed Care Pharmacy (AMCP) thanks the Office of Management and Budget (OMB) for the opportunity to provide comments in response to the proposed rule titled Regulation for Federal Financial Assistance.

AMCP's Q3 2026 Precision Medicine Bulletin is now available, featuring a recap of key precision medicine developments from 2026, a review of recent clinical guidelines, highlights from new publications in the field, and updates on AMCP's submission to the National Comprehensive Cancer Network (NCCN).

The Academy of Managed Care Pharmacy (AMCP) convened stakeholders across managed care, patient advocacy, life sciences, and research for its Partnership Forum, Insights to Impact: Advancing the Use of Patient Experience Data in Payer Decision-Making, held in Alexandria, Va., in June 2026. The forum focused on how patient experience data (PED) can be more consistently evaluated and applied within payer decision-making frameworks.